ABOUT 1142

A research collective dedicated to breakthrough discoveries in neuroscience, pharmacology, and consciousness studies. Established December 22nd, 2019.

OUR MISSION

To advance human knowledge through rigorous empirical research, challenging conventional understanding of neurodevelopment, pharmacology, and consciousness. We pursue breakthrough discoveries that push the boundaries of scientific understanding and provide practical solutions for real-world challenges.

BY THE NUMBERS

20+
Research Papers
2019
Established
5+
Years Active
Discoveries Ahead

THE ORIGIN

December 22nd, 2019

1142 Labs was founded on the winter solstice of 2019 with a singular vision: to challenge the boundaries of conventional neuroscience and pharmacology research. What began as an independent research initiative has evolved into a comprehensive body of work spanning neurodevelopment, consciousness studies, and breakthrough pharmacological discoveries.

The name "1142" represents more than a numerical designation—it embodies a philosophy of precision, clarity, and the pursuit of knowledge at the intersection of science and consciousness. Every research paper, every discovery, every breakthrough carries the weight of this mission.

THE FOUNDER

Cole EverDark

Cole EverDark

Creator, researcher, and visionary behind 1142 Labs. Cole EverDark has authored over 20 research papers exploring the frontiers of neuroscience, pharmacology, and consciousness studies. His work challenges conventional paradigms and offers new frameworks for understanding cognitive enhancement, neurodevelopment, and the intersection of pharmacology and human potential.

With a background spanning empirical research, systems thinking, and creative synthesis, Cole brings a unique perspective to scientific inquiry—one that values both rigorous methodology and bold exploration of uncharted territories.

CORE VALUES

🔬

Empirical Rigor

Every claim is backed by data. Every hypothesis is tested. We believe in the power of the scientific method to reveal truth.

💡

Bold Innovation

We challenge conventional wisdom and explore ideas others dismiss. Breakthrough discoveries require breakthrough thinking.

🧠

Consciousness First

Understanding the mind is the key to unlocking human potential. Our research centers on the mechanisms of consciousness and cognition.

Practical Impact

Research must serve humanity. We focus on discoveries that offer real-world solutions to pressing challenges.

🌐

Open Knowledge

Science belongs to everyone. We share our findings openly to accelerate collective understanding.

🔮

Future-Focused

We don't just study what is—we explore what could be. Tomorrow's solutions are being built today.

TIMELINE

December 22, 2019
1142 Labs officially established. Initial research focus on neurodevelopment and pharmacology.
2020-2021
First wave of breakthrough research papers published. Development of novel frameworks for understanding cognitive enhancement and withdrawal support.
2022-2023
Expansion into consciousness studies and advanced pharmacological research. Publication of comprehensive methylphenidate research series.
2024-2025
Launch of 1142 Labs digital presence. Development of interactive tools and resources for researchers and practitioners.
2026 & Beyond
Continued research expansion. New discoveries in neuroscience, pharmacology, and the frontiers of human consciousness.

Research Philosophy

At 1142 Labs, we believe that the most important discoveries lie at the intersection of disciplines. Our research methodology combines rigorous empirical analysis with creative synthesis, allowing us to see patterns and connections that traditional siloed approaches might miss.

We approach every question with intellectual humility and scientific courage—humble enough to acknowledge what we don't know, courageous enough to challenge what we think we do. This balance drives us toward genuine breakthroughs rather than incremental refinements of existing paradigms.

Our work is guided by a simple principle: truth over comfort. We follow the data wherever it leads, even when it contradicts prevailing assumptions or challenges established orthodoxy. This commitment to intellectual honesty is the foundation of everything we do.